chr9-35737254-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_020944.3(GBA2):c.2699G>A(p.Trp900*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,613,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020944.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBA2 | ENST00000378103.7 | c.2699G>A | p.Trp900* | stop_gained | Exon 17 of 17 | 1 | NM_020944.3 | ENSP00000367343.3 | ||
GBA2 | ENST00000378094 | c.*222G>A | 3_prime_UTR_variant | Exon 17 of 17 | 1 | ENSP00000367334.4 | ||||
GBA2 | ENST00000378088 | c.*383G>A | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000367328.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251094Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135728
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461590Hom.: 0 Cov.: 32 AF XY: 0.0000316 AC XY: 23AN XY: 727110
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. This variant has not been reported in the literature in individuals with GBA2-related conditions. This variant is present in population databases (rs767031907, ExAC 0.009%). This sequence change results in a premature translational stop signal in the GBA2 gene (p.Trp900*). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 28 amino acids of the GBA2 protein. -
Hereditary spastic paraplegia Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at